
RegenXBio Inc. (($RGNX)) has held its Q3 earnings call. Read on for the main highlights of the call. REGENXBIO’s earnings call carried a strongly optimistic tone, driven by progress in
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RGNX | RegenXBio | 7.18 | -3.57 | -33.21% |
| Name | Price | % Change | |
|---|---|---|---|
| $7.18 | -33.21% |

RegenXBio Inc. (($RGNX)) has held its Q3 earnings call. Read on for the main highlights of the call. REGENXBIO’s earnings call carried a strongly optimistic tone, driven by progress in

H.C. Wainwright analyst Yi Chen has reiterated their bullish stance on RGNX stock, giving a Buy rating today. Yi Chen has given his Buy rating due to a combination of

BofA lowered the firm’s price target on Regenxbio (RGNX) to $14 from $15 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source for

Mizuho lowered the firm’s price target on Regenxbio (RGNX) to $18 from $19 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source for

Baird analyst Brian Skorney lowered the firm’s price target on Regenxbio (RGNX) to $25 from $29 and keeps an Outperform rating on the shares. The firm updated its model following

Reports Q3 revenue $9.2M, consensus $10.68M. “We are continuing to build momentum as we prepare to launch potential first- or best-in-class gene therapies in 2027 and 2028,” said Curran Simpson,

Mizuho analyst Graig Suvannavejh lowered the firm’s price target on Regenxbio (RGNX) to $19 from $22 and keeps an Outperform rating on the shares. Published first on TheFly – the

Morgan Stanley analyst Maxwell Skor has maintained their bullish stance on RGNX stock, giving a Buy rating today. Maxwell Skor has given his Buy rating due to a combination of

RegenXBio ( ($RGNX) ) has issued an announcement. On October 14, 2026, REGENXBIO director Kenneth T. Mills tendered his resignation from the board, effective October 21, 2026, following his appointment

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| hold | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| buy | Reiterated | Oct 21, 2026 | ||||
| hold | Reiterated | Oct 20, 2026 | ||||
| buy | Reiterated | Oct 12, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 2, 2027TBA | $480.05M | $-0.96 | $28.32M | 0.21 | -2.26 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.